SPC Life Sciences Ltd. logo

SPC Life Sciences Ltd. IPO Details

SPC Life Sciences was founded on June 15, 2005, with a focus on research and development-driven chemical manufacturing. The company is a manufacturer of advanced intermediates for certain key active pharmaceutical ingredients, including pentoxifylline, amiodarone HCl, cilostazol, trazodone, tramadol, and paroxetine. It specializes in chemistries involving long-chain multi-stage reactions.